N-[1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-3-[2-[1-(4-methylphenyl)-3-pyridin-4-ylpyrazol-5-yl]ethyl]benzamide;2-[[1-(4-tert-butylphenyl)-3-pyridin-3-ylpyrazol-5-yl]methylamino]-N-[2-(4-hydroxyphenyl)ethyl]acetamide;(2R)-5-[[1-(4-tert-butylphenyl)-3-pyridin-3-ylpyrazol-5-yl]methylamino]-2-[(4-hydroxyphenyl)methyl]-4-oxopentanamide;4-(1-phenyl-3-pyridin-3-ylpyrazol-5-yl)benzamide;sulfane;2,2,2-trifluoro-N-[1-(4-methylphenyl)-3-pyridin-4-ylpyrazol-5-yl]acetamide

C131H132F3N23O10S2 — CID 159056972

IUPACN-[1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-3-[2-[1-(4-methylphenyl)-3-pyridin-4-ylpyrazol-5-yl]ethyl]benzamide;2-[[1-(4-tert-butylphenyl)-3-pyridin-3-ylpyrazol-5-yl]methylamino]-N-[2-(4-hydroxyphenyl)ethyl]acetamide;(2R)-5-[[1-(4-tert-butylphenyl)-3-pyridin-3-ylpyrazol-5-yl]methylamino]-2-[(4-hydroxyphenyl)methyl]-4-oxopentanamide;4-(1-phenyl-3-pyridin-3-ylpyrazol-5-yl)benzamide;sulfane;2,2,2-trifluoro-N-[1-(4-methylphenyl)-3-pyridin-4-ylpyrazol-5-yl]acetamide
SMILESCC(C)(C)c1ccc(-n2nc(-c3cccnc3)cc2CNCC(=O)C[C@@H](Cc2ccc(O)cc2)C(N)=O)cc1.CC(C)(C)c1ccc(-n2nc(-c3cccnc3)cc2CNCC(=O)NCCc2ccc(O)cc2)cc1.Cc1ccc(-n2nc(-c3ccncc3)cc2CCc2cccc(C(=O)NC(Cc3ccc(O)cc3)C(N)=O)c2)cc1.Cc1ccc(-n2nc(-c3ccncc3)cc2NC(=O)C(F)(F)F)cc1.NC(=O)c1ccc(-c2cc(-c3cccnc3)nn2-c2ccccc2)cc1.S.S
InChIInChI=1S/C33H31N5O3.C31H35N5O3.C29H33N5O2.C21H16N4O.C17H13F3N4O.2H2S/c1-22-5-10-27(11-6-22)38-28(21-30(37-38)25-15-17-35-18-16-25)12-7-23-3-2-4-26(19-23)33(41)36-31(32(34)40)20-24-8-13-29(39)14-9-24;1-31(2,3)24-8-10-25(11-9-24)36-26(17-29(35-36)22-5-4-14-33-18-22)19-34-20-28(38)16-23(30(32)39)15-21-6-12-27(37)13-7-21;1-29(2,3)23-8-10-24(11-9-23)34-25(17-27(33-34)22-5-4-15-30-18-22)19-31-20-28(36)32-16-14-21-6-12-26(35)13-7-21;22-21(26)16-10-8-15(9-11-16)20-13-19(17-5-4-12-23-14-17)24-25(20)18-6-2-1-3-7-18;1-11-2-4-13(5-3-11)24-15(22-16(25)17(18,19)20)10-14(23-24)12-6-8-21-9-7-12;;/h2-6,8-11,13-19,21,31,39H,7,12,20H2,1H3,(H2,34,40)(H,36,41);4-14,17-18,23,34,37H,15-16,19-20H2,1-3H3,(H2,32,39);4-13,15,17-18,31,35H,14,16,19-20H2,1-3H3,(H,32,36);1-14H,(H2,22,26);2-10H,1H3,(H,22,25);2*1H2/t;23-;;;;;/m.1...../s1
InChIKeyJXZCNQDTTJIBHB-LXYGXCMPSA-N
MW2309.78 g/mol
LogP20.95
Rot. Bonds37

About N-[1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-3-[2-[1-(4-methylphenyl)-3-pyridin-4-ylpyrazol-5-yl]ethyl]benzamide;2-[[1-(4-tert-butylphenyl)-3-pyridin-3-ylpyrazol-5-yl]methylamino]-N-[2-(4-hydroxyphenyl)ethyl]acetamide;(2R)-5-[[1-(4-tert-butylphenyl)-3-pyridin-3-ylpyrazol-5-yl]methylamino]-2-[(4-hydroxyphenyl)methyl]-4-oxopentanamide;4-(1-phenyl-3-pyridin-3-ylpyrazol-5-yl)benzamide;sulfane;2,2,2-trifluoro-N-[1-(4-methylphenyl)-3-pyridin-4-ylpyrazol-5-yl]acetamide

N-[1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-3-[2-[1-(4-methylphenyl)-3-pyridin-4-ylpyrazol-5-yl]ethyl]benzamide;2-[[1-(4-tert-butylphenyl)-3-pyridin-3-ylpyrazol-5-yl]methylamino]-N-[2-(4-hydroxyphenyl)ethyl]acetamide;(2R)-5-[[1-(4-tert-butylphenyl)-3-pyridin-3-ylpyrazol-5-yl]methylamino]-2-[(4-hydroxyphenyl)methyl]-4-oxopentanamide;4-(1-phenyl-3-pyridin-3-ylpyrazol-5-yl)benzamide;sulfane;2,2,2-trifluoro-N-[1-(4-methylphenyl)-3-pyridin-4-ylpyrazol-5-yl]acetamide (PubChem CID 159056972) has the molecular formula C131H132F3N23O10S2 and a molecular weight of 2309.78 g/mol. Its IUPAC name is N-[1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-3-[2-[1-(4-methylphenyl)-3-pyridin-4-ylpyrazol-5-yl]ethyl]benzamide;2-[[1-(4-tert-butylphenyl)-3-pyridin-3-ylpyrazol-5-yl]methylamino]-N-[2-(4-hydroxyphenyl)ethyl]acetamide;(2R)-5-[[1-(4-tert-butylphenyl)-3-pyridin-3-ylpyrazol-5-yl]methylamino]-2-[(4-hydroxyphenyl)methyl]-4-oxopentanamide;4-(1-phenyl-3-pyridin-3-ylpyrazol-5-yl)benzamide;sulfane;2,2,2-trifluoro-N-[1-(4-methylphenyl)-3-pyridin-4-ylpyrazol-5-yl]acetamide.

Molecular Properties

Compound NameN-[1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-3-[2-[1-(4-methylphenyl)-3-pyridin-4-ylpyrazol-5-yl]ethyl]benzamide;2-[[1-(4-tert-butylphenyl)-3-pyridin-3-ylpyrazol-5-yl]methylamino]-N-[2-(4-hydroxyphenyl)ethyl]acetamide;(2R)-5-[[1-(4-tert-butylphenyl)-3-pyridin-3-ylpyrazol-5-yl]methylamino]-2-[(4-hydroxyphenyl)methyl]-4-oxopentanamide;4-(1-phenyl-3-pyridin-3-ylpyrazol-5-yl)benzamide;sulfane;2,2,2-trifluoro-N-[1-(4-methylphenyl)-3-pyridin-4-ylpyrazol-5-yl]acetamide
PubChem CID159056972
Molecular FormulaC131H132F3N23O10S2
Molecular Weight2309.78 g/mol
Exact Mass2307.99
IUPAC NameN-[1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-3-[2-[1-(4-methylphenyl)-3-pyridin-4-ylpyrazol-5-yl]ethyl]benzamide;2-[[1-(4-tert-butylphenyl)-3-pyridin-3-ylpyrazol-5-yl]methylamino]-N-[2-(4-hydroxyphenyl)ethyl]acetamide;(2R)-5-[[1-(4-tert-butylphenyl)-3-pyridin-3-ylpyrazol-5-yl]methylamino]-2-[(4-hydroxyphenyl)methyl]-4-oxopentanamide;4-(1-phenyl-3-pyridin-3-ylpyrazol-5-yl)benzamide;sulfane;2,2,2-trifluoro-N-[1-(4-methylphenyl)-3-pyridin-4-ylpyrazol-5-yl]acetamide
SMILESCC(C)(C)c1ccc(-n2nc(-c3cccnc3)cc2CNCC(=O)C[C@@H](Cc2ccc(O)cc2)C(N)=O)cc1.CC(C)(C)c1ccc(-n2nc(-c3cccnc3)cc2CNCC(=O)NCCc2ccc(O)cc2)cc1.Cc1ccc(-n2nc(-c3ccncc3)cc2CCc2cccc(C(=O)NC(Cc3ccc(O)cc3)C(N)=O)c2)cc1.Cc1ccc(-n2nc(-c3ccncc3)cc2NC(=O)C(F)(F)F)cc1.NC(=O)c1ccc(-c2cc(-c3cccnc3)nn2-c2ccccc2)cc1.S.S
InChIInChI=1S/C33H31N5O3.C31H35N5O3.C29H33N5O2.C21H16N4O.C17H13F3N4O.2H2S/c1-22-5-10-27(11-6-22)38-28(21-30(37-38)25-15-17-35-18-16-25)12-7-23-3-2-4-26(19-23)33(41)36-31(32(34)40)20-24-8-13-29(39)14-9-24;1-31(2,3)24-8-10-25(11-9-24)36-26(17-29(35-36)22-5-4-14-33-18-22)19-34-20-28(38)16-23(30(32)39)15-21-6-12-27(37)13-7-21;1-29(2,3)23-8-10-24(11-9-23)34-25(17-27(33-34)22-5-4-15-30-18-22)19-31-20-28(36)32-16-14-21-6-12-26(35)13-7-21;22-21(26)16-10-8-15(9-11-16)20-13-19(17-5-4-12-23-14-17)24-25(20)18-6-2-1-3-7-18;1-11-2-4-13(5-3-11)24-15(22-16(25)17(18,19)20)10-14(23-24)12-6-8-21-9-7-12;;/h2-6,8-11,13-19,21,31,39H,7,12,20H2,1H3,(H2,34,40)(H,36,41);4-14,17-18,23,34,37H,15-16,19-20H2,1-3H3,(H2,32,39);4-13,15,17-18,31,35H,14,16,19-20H2,1-3H3,(H,32,36);1-14H,(H2,22,26);2-10H,1H3,(H,22,25);2*1H2/t;23-;;;;;/m.1...../s1
InChIKeyJXZCNQDTTJIBHB-LXYGXCMPSA-N
XLogP20.95
TPSA471.94 Ų
H-Bond Donors11
H-Bond Acceptors27
Rotatable Bonds37
Heavy Atoms169
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002309.78
LogP ≤ 520.95
H-Bond Donors ≤ 511
H-Bond Acceptors ≤ 1027

Analyze N-[1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-3-[2-[1-(4-methylphenyl)-3-pyridin-4-ylpyrazol-5-yl]ethyl]benzamide;2-[[1-(4-tert-butylphenyl)-3-pyridin-3-ylpyrazol-5-yl]methylamino]-N-[2-(4-hydroxyphenyl)ethyl]acetamide;(2R)-5-[[1-(4-tert-butylphenyl)-3-pyridin-3-ylpyrazol-5-yl]methylamino]-2-[(4-hydroxyphenyl)methyl]-4-oxopentanamide;4-(1-phenyl-3-pyridin-3-ylpyrazol-5-yl)benzamide;sulfane;2,2,2-trifluoro-N-[1-(4-methylphenyl)-3-pyridin-4-ylpyrazol-5-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-3-[2-[1-(4-methylphenyl)-3-pyridin-4-ylpyrazol-5-yl]ethyl]benzamide;2-[[1-(4-tert-butylphenyl)-3-pyridin-3-ylpyrazol-5-yl]methylamino]-N-[2-(4-hydroxyphenyl)ethyl]acetamide;(2R)-5-[[1-(4-tert-butylphenyl)-3-pyridin-3-ylpyrazol-5-yl]methylamino]-2-[(4-hydroxyphenyl)methyl]-4-oxopentanamide;4-(1-phenyl-3-pyridin-3-ylpyrazol-5-yl)benzamide;sulfane;2,2,2-trifluoro-N-[1-(4-methylphenyl)-3-pyridin-4-ylpyrazol-5-yl]acetamide?
The IUPAC name of N-[1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-3-[2-[1-(4-methylphenyl)-3-pyridin-4-ylpyrazol-5-yl]ethyl]benzamide;2-[[1-(4-tert-butylphenyl)-3-pyridin-3-ylpyrazol-5-yl]methylamino]-N-[2-(4-hydroxyphenyl)ethyl]acetamide;(2R)-5-[[1-(4-tert-butylphenyl)-3-pyridin-3-ylpyrazol-5-yl]methylamino]-2-[(4-hydroxyphenyl)methyl]-4-oxopentanamide;4-(1-phenyl-3-pyridin-3-ylpyrazol-5-yl)benzamide;sulfane;2,2,2-trifluoro-N-[1-(4-methylphenyl)-3-pyridin-4-ylpyrazol-5-yl]acetamide (CID 159056972) is N-[1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-3-[2-[1-(4-methylphenyl)-3-pyridin-4-ylpyrazol-5-yl]ethyl]benzamide;2-[[1-(4-tert-butylphenyl)-3-pyridin-3-ylpyrazol-5-yl]methylamino]-N-[2-(4-hydroxyphenyl)ethyl]acetamide;(2R)-5-[[1-(4-tert-butylphenyl)-3-pyridin-3-ylpyrazol-5-yl]methylamino]-2-[(4-hydroxyphenyl)methyl]-4-oxopentanamide;4-(1-phenyl-3-pyridin-3-ylpyrazol-5-yl)benzamide;sulfane;2,2,2-trifluoro-N-[1-(4-methylphenyl)-3-pyridin-4-ylpyrazol-5-yl]acetamide.
What is the SMILES notation for N-[1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-3-[2-[1-(4-methylphenyl)-3-pyridin-4-ylpyrazol-5-yl]ethyl]benzamide;2-[[1-(4-tert-butylphenyl)-3-pyridin-3-ylpyrazol-5-yl]methylamino]-N-[2-(4-hydroxyphenyl)ethyl]acetamide;(2R)-5-[[1-(4-tert-butylphenyl)-3-pyridin-3-ylpyrazol-5-yl]methylamino]-2-[(4-hydroxyphenyl)methyl]-4-oxopentanamide;4-(1-phenyl-3-pyridin-3-ylpyrazol-5-yl)benzamide;sulfane;2,2,2-trifluoro-N-[1-(4-methylphenyl)-3-pyridin-4-ylpyrazol-5-yl]acetamide?
The canonical SMILES for N-[1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-3-[2-[1-(4-methylphenyl)-3-pyridin-4-ylpyrazol-5-yl]ethyl]benzamide;2-[[1-(4-tert-butylphenyl)-3-pyridin-3-ylpyrazol-5-yl]methylamino]-N-[2-(4-hydroxyphenyl)ethyl]acetamide;(2R)-5-[[1-(4-tert-butylphenyl)-3-pyridin-3-ylpyrazol-5-yl]methylamino]-2-[(4-hydroxyphenyl)methyl]-4-oxopentanamide;4-(1-phenyl-3-pyridin-3-ylpyrazol-5-yl)benzamide;sulfane;2,2,2-trifluoro-N-[1-(4-methylphenyl)-3-pyridin-4-ylpyrazol-5-yl]acetamide is CC(C)(C)c1ccc(-n2nc(-c3cccnc3)cc2CNCC(=O)C[C@@H](Cc2ccc(O)cc2)C(N)=O)cc1.CC(C)(C)c1ccc(-n2nc(-c3cccnc3)cc2CNCC(=O)NCCc2ccc(O)cc2)cc1.Cc1ccc(-n2nc(-c3ccncc3)cc2CCc2cccc(C(=O)NC(Cc3ccc(O)cc3)C(N)=O)c2)cc1.Cc1ccc(-n2nc(-c3ccncc3)cc2NC(=O)C(F)(F)F)cc1.NC(=O)c1ccc(-c2cc(-c3cccnc3)nn2-c2ccccc2)cc1.S.S.
What is the InChIKey of N-[1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-3-[2-[1-(4-methylphenyl)-3-pyridin-4-ylpyrazol-5-yl]ethyl]benzamide;2-[[1-(4-tert-butylphenyl)-3-pyridin-3-ylpyrazol-5-yl]methylamino]-N-[2-(4-hydroxyphenyl)ethyl]acetamide;(2R)-5-[[1-(4-tert-butylphenyl)-3-pyridin-3-ylpyrazol-5-yl]methylamino]-2-[(4-hydroxyphenyl)methyl]-4-oxopentanamide;4-(1-phenyl-3-pyridin-3-ylpyrazol-5-yl)benzamide;sulfane;2,2,2-trifluoro-N-[1-(4-methylphenyl)-3-pyridin-4-ylpyrazol-5-yl]acetamide?
The InChIKey is JXZCNQDTTJIBHB-LXYGXCMPSA-N. The full InChI is InChI=1S/C33H31N5O3.C31H35N5O3.C29H33N5O2.C21H16N4O.C17H13F3N4O.2H2S/c1-22-5-10-27(11-6-22)38-28(21-30(37-38)25-15-17-35-18-16-25)12-7-23-3-2-4-26(19-23)33(41)36-31(32(34)40)20-24-8-13-29(39)14-9-24;1-31(2,3)24-8-10-25(11-9-24)36-26(17-29(35-36)22-5-4-14-33-18-22)19-34-20-28(38)16-23(30(32)39)15-21-6-12-27(37)13-7-21;1-29(2,3)23-8-10-24(11-9-23)34-25(17-27(33-34)22-5-4-15-30-18-22)19-31-20-28(36)32-16-14-21-6-12-26(35)13-7-21;22-21(26)16-10-8-15(9-11-16)20-13-19(17-5-4-12-23-14-17)24-25(20)18-6-2-1-3-7-18;1-11-2-4-13(5-3-11)24-15(22-16(25)17(18,19)20)10-14(23-24)12-6-8-21-9-7-12;;/h2-6,8-11,13-19,21,31,39H,7,12,20H2,1H3,(H2,34,40)(H,36,41);4-14,17-18,23,34,37H,15-16,19-20H2,1-3H3,(H2,32,39);4-13,15,17-18,31,35H,14,16,19-20H2,1-3H3,(H,32,36);1-14H,(H2,22,26);2-10H,1H3,(H,22,25);2*1H2/t;23-;;;;;/m.1...../s1.
What are the key properties of N-[1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-3-[2-[1-(4-methylphenyl)-3-pyridin-4-ylpyrazol-5-yl]ethyl]benzamide;2-[[1-(4-tert-butylphenyl)-3-pyridin-3-ylpyrazol-5-yl]methylamino]-N-[2-(4-hydroxyphenyl)ethyl]acetamide;(2R)-5-[[1-(4-tert-butylphenyl)-3-pyridin-3-ylpyrazol-5-yl]methylamino]-2-[(4-hydroxyphenyl)methyl]-4-oxopentanamide;4-(1-phenyl-3-pyridin-3-ylpyrazol-5-yl)benzamide;sulfane;2,2,2-trifluoro-N-[1-(4-methylphenyl)-3-pyridin-4-ylpyrazol-5-yl]acetamide?
N-[1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-3-[2-[1-(4-methylphenyl)-3-pyridin-4-ylpyrazol-5-yl]ethyl]benzamide;2-[[1-(4-tert-butylphenyl)-3-pyridin-3-ylpyrazol-5-yl]methylamino]-N-[2-(4-hydroxyphenyl)ethyl]acetamide;(2R)-5-[[1-(4-tert-butylphenyl)-3-pyridin-3-ylpyrazol-5-yl]methylamino]-2-[(4-hydroxyphenyl)methyl]-4-oxopentanamide;4-(1-phenyl-3-pyridin-3-ylpyrazol-5-yl)benzamide;sulfane;2,2,2-trifluoro-N-[1-(4-methylphenyl)-3-pyridin-4-ylpyrazol-5-yl]acetamide has a molecular weight of 2309.78 g/mol, XLogP of 20.95, 37 rotatable bonds, 11 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for N-[1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-3-[2-[1-(4-methylphenyl)-3-pyridin-4-ylpyrazol-5-yl]ethyl]benzamide;2-[[1-(4-tert-butylphenyl)-3-pyridin-3-ylpyrazol-5-yl]methylamino]-N-[2-(4-hydroxyphenyl)ethyl]acetamide;(2R)-5-[[1-(4-tert-butylphenyl)-3-pyridin-3-ylpyrazol-5-yl]methylamino]-2-[(4-hydroxyphenyl)methyl]-4-oxopentanamide;4-(1-phenyl-3-pyridin-3-ylpyrazol-5-yl)benzamide;sulfane;2,2,2-trifluoro-N-[1-(4-methylphenyl)-3-pyridin-4-ylpyrazol-5-yl]acetamide is sourced from PubChem (CID 159056972), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).